Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study
- EICOV/COVIM Study Group
Research output: Contribution to journal › Article › Research › peer-review
283
Citations
(Scopus)